{"recordsFiltered":48602,"recordsTotal":48602,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=41700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=41100","results":[{"registry_id":"NCT06735534","publication_url":"https://clinicaltrials.gov/study/NCT06735534","title":"The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters","has_exemption":false,"start_date":"2025-06-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06895473","publication_url":"https://clinicaltrials.gov/study/NCT06895473","title":"A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968494","publication_url":"https://clinicaltrials.gov/study/NCT06968494","title":"Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Comphya Inc.","sponsor_slug":"comphya-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999304","publication_url":"https://clinicaltrials.gov/study/NCT06999304","title":"Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2025-06-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033026","publication_url":"https://clinicaltrials.gov/study/NCT07033026","title":"A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"NGM Biopharmaceuticals, Inc","sponsor_slug":"ngm-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740890","publication_url":"https://clinicaltrials.gov/study/NCT06740890","title":"A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07113522","publication_url":"https://clinicaltrials.gov/study/NCT07113522","title":"A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Mirador Therapeutics, Inc.","sponsor_slug":"mirador-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665100","publication_url":"https://clinicaltrials.gov/study/NCT06665100","title":"Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients With Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) With Documented Viral Infections With PIV, hMPV or RSV","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulmotect, Inc.","sponsor_slug":"pulmotect-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07025720","publication_url":"https://clinicaltrials.gov/study/NCT07025720","title":"Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095660","publication_url":"https://clinicaltrials.gov/study/NCT07095660","title":"RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)","has_exemption":false,"start_date":"2025-07-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intervene, Inc.","sponsor_slug":"intervene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217392","publication_url":"https://clinicaltrials.gov/study/NCT07217392","title":"Left Bundle Branch Area Pacing (LBBAP) PMCF Study","has_exemption":false,"start_date":"2025-07-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079761","publication_url":"https://clinicaltrials.gov/study/NCT07079761","title":"Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.","has_exemption":false,"start_date":"2025-08-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864403","publication_url":"https://clinicaltrials.gov/study/NCT06864403","title":"Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968143","publication_url":"https://clinicaltrials.gov/study/NCT06968143","title":"Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999603","publication_url":"https://clinicaltrials.gov/study/NCT06999603","title":"A Phase 2, Two-part Study to Assess the Safety, Antiviral Biomarker Responses, and Efficacy of Inhaled SNG001 for the Treatment of Patients With a Confirmed Respiratory Virus Infection Undergoing Invasive Mechanical Ventilation","has_exemption":false,"start_date":"2025-09-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Synairgen Research Ltd.","sponsor_slug":"synairgen-research-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915662","publication_url":"https://clinicaltrials.gov/study/NCT06915662","title":"Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap: A Prospective Trial for Safety and Efficacy","has_exemption":false,"start_date":"2025-09-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220460","publication_url":"https://clinicaltrials.gov/study/NCT07220460","title":"Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219771","publication_url":"https://clinicaltrials.gov/study/NCT07219771","title":"A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis","has_exemption":false,"start_date":"2025-10-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Doron Therapeutics Inc.","sponsor_slug":"doron-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220811","publication_url":"https://clinicaltrials.gov/study/NCT07220811","title":"Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"RAPT Therapeutics, Inc.","sponsor_slug":"rapt-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959121","publication_url":"https://clinicaltrials.gov/study/NCT06959121","title":"Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery","has_exemption":false,"start_date":"2025-10-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulse Biosciences, Inc.","sponsor_slug":"pulse-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06804811","publication_url":"https://clinicaltrials.gov/study/NCT06804811","title":"A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658899","publication_url":"https://clinicaltrials.gov/study/NCT06658899","title":"A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Cardurion Pharmaceuticals, Inc.","sponsor_slug":"cardurion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090135","publication_url":"https://clinicaltrials.gov/study/NCT07090135","title":"Enhance the Restorative Power of Sleep Through TES-TI Power Naps","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400952","publication_url":"https://clinicaltrials.gov/study/NCT07400952","title":"Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221734","publication_url":"https://clinicaltrials.gov/study/NCT07221734","title":"Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"mAbxience Research S.L.","sponsor_slug":"mabxience-research-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222969","publication_url":"https://clinicaltrials.gov/study/NCT07222969","title":"An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-01-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Vibrant Sciences Limited","sponsor_slug":"vibrant-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282743","publication_url":"https://clinicaltrials.gov/study/NCT07282743","title":"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of GL0034 Among Type II Diabetes Mellitus Subjects Who Are Obese or Overweight With Weight-related Comorbidities","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07141342","publication_url":"https://clinicaltrials.gov/study/NCT07141342","title":"The Fast In-Bed Tracking (FIT) System Lifestyle Intervention","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Jonathan Pearlman","sponsor_slug":"jonathan-pearlman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486713","publication_url":"https://clinicaltrials.gov/study/NCT07486713","title":"A Multi-Center, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Olutasidenib on the Pharmacokinetics of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and OATP1B1 Substrates in Patients With IDH1 Mutation-Positive Malignancies Being Treated With Olutasidenib","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369076","publication_url":"https://clinicaltrials.gov/study/NCT07369076","title":"A Phase 1b/2 Study to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Nura Bio","sponsor_slug":"nura-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06875206","publication_url":"https://clinicaltrials.gov/study/NCT06875206","title":"Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523191","publication_url":"https://clinicaltrials.gov/study/NCT07523191","title":"Prospective Validation of a Reduced-Montage TMS-EEG Complexity Algorithm (Presence-IP1.0) to Differentiate Conscious and Unconscious States Across Wakefulness and Sleep","has_exemption":false,"start_date":"2026-03-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07078604","publication_url":"https://clinicaltrials.gov/study/NCT07078604","title":"A Phase II Trial of the Immunogenicity of a DNA Plasmid-Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes From Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Patients With Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2026-03-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086534","publication_url":"https://clinicaltrials.gov/study/NCT07086534","title":"A Clinical Study of GeminiOne Transcatheter Edge-to-Edge Repair (TEER) System for the Treatment of Severe, Symptomatic Mitral Regurgitation (MR).","has_exemption":false,"start_date":"2026-03-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sierra Valve LLC","sponsor_slug":"sierra-valve-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224958","publication_url":"https://clinicaltrials.gov/study/NCT07224958","title":"ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346066","publication_url":"https://clinicaltrials.gov/study/NCT07346066","title":"A Phase 3 Multi-Center Efficacy Study of Filricianine Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci Surgical System With Firefly® Fluorescence Imaging","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477171","publication_url":"https://clinicaltrials.gov/study/NCT07477171","title":"Comparison of Two Root Canal Filling Materials in Non-Surgical Endodontic Retreatment: A Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Santiago de Compostela","sponsor_slug":"university-of-santiago-de-compostela","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07504198","publication_url":"https://clinicaltrials.gov/study/NCT07504198","title":"Neuroprotective Effect of Memantine and Rosuvastatin Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536022","publication_url":"https://clinicaltrials.gov/study/NCT07536022","title":"Developing At-home taVNS for Neurorehabilitation in Parkinson's Disease","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07175441","publication_url":"https://clinicaltrials.gov/study/NCT07175441","title":"A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2026-04-10","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Riboscience, LLC.","sponsor_slug":"riboscience-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07544251","publication_url":"https://clinicaltrials.gov/study/NCT07544251","title":"The Effects of Sarecycline Versus Doxycycline on the Gut Microbiome and Skin Microbiome in Acne.","has_exemption":false,"start_date":"2026-04-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Integrative Skin Science and Research","sponsor_slug":"integrative-skin-science-and-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333041","publication_url":"https://clinicaltrials.gov/study/NCT06333041","title":"Randomized, Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Effects of Cannabidiol on Neurobehavioral and Function Outcomes in Sanfilippo Syndrome","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","sponsor_slug":"lundquist-institute-for-biomedical-innovation-at-harbor-ucla-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06623305","publication_url":"https://clinicaltrials.gov/study/NCT06623305","title":"Photobiomodulation Therapy for the Prevention and Treatment of Mucositis in Pediatric Oncology Patients","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553651","publication_url":"https://clinicaltrials.gov/study/NCT06553651","title":"Necrosectomy With Cryotechnology for Accelerated Removal","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Christopher C. Thompson, MD, MSc","sponsor_slug":"christopher-c-thompson-md-msc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07045298","publication_url":"https://clinicaltrials.gov/study/NCT07045298","title":"Real-Time Continuous Glucose Monitoring for the Management of Patients With Type 2 Diabetes and Acutely Decompensated Heart Failure","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296744","publication_url":"https://clinicaltrials.gov/study/NCT07296744","title":"Pivotal Randomized Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Supira Medical","sponsor_slug":"supira-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342595","publication_url":"https://clinicaltrials.gov/study/NCT07342595","title":"Clinical Performance of an Intraoral Scanner With Integrated Caries Detection","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Albert Mehl","sponsor_slug":"albert-mehl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342465","publication_url":"https://clinicaltrials.gov/study/NCT07342465","title":"Safety, Feasibility, and Preliminary Efficacy of Non-invasive Gamma Neuromodulation in Individuals With Schizophrenia Spectrum Disorders","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07408154","publication_url":"https://clinicaltrials.gov/study/NCT07408154","title":"A Randomized Controlled Trial Comparing Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT) in Reducing Intraocular Pressure in Open-Angle Glaucoma","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07426822","publication_url":"https://clinicaltrials.gov/study/NCT07426822","title":"A Phase II Trial to Improve Safety of Capivasertib for HR+/HER2- Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Maryam Lustberg","sponsor_slug":"maryam-lustberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07520851","publication_url":"https://clinicaltrials.gov/study/NCT07520851","title":"Efficacy of the Buzzy System on Pain and Fear Reduction in Elbow Fracture Pin Removal","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517679","publication_url":"https://clinicaltrials.gov/study/NCT07517679","title":"Effect of Post-Induction Methadone on Postoperative Pain, Opioid Use, and Recovery in Spine Surgery","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Brandon Knopp","sponsor_slug":"brandon-knopp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553273","publication_url":"https://clinicaltrials.gov/study/NCT07553273","title":"The Effect of Vibratory Anesthesia on Patient Pain Perception in Corticosteroid Injections of the Upper Extremity","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487246","publication_url":"https://clinicaltrials.gov/study/NCT07487246","title":"Effects of Paracervical Block With Combined Ketorolac and Lidocaine on Perceived Pain in Osmotic Dilator Placement for Abortion, a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07517770","publication_url":"https://clinicaltrials.gov/study/NCT07517770","title":"Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sue Brown","sponsor_slug":"sue-brown","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06748144","publication_url":"https://clinicaltrials.gov/study/NCT06748144","title":"Intraosseous vs. Intravenous Vancomycin Administration in Spine Surgery","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07534332","publication_url":"https://clinicaltrials.gov/study/NCT07534332","title":"Therapeutic Targeting of Gasdermin D-Mediated Pyroptosis to Attenuate Joint Inflammation in Rheumatoid Arthritis","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03301805","publication_url":"https://clinicaltrials.gov/study/NCT03301805","title":"A Phase II, Open Label Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Gemcitabine Monotherapy in Patients With Advanced Inoperable or Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rgene Corporation","sponsor_slug":"rgene-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07423546","publication_url":"https://clinicaltrials.gov/study/NCT07423546","title":"A Multimodal PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218432","publication_url":"https://clinicaltrials.gov/study/NCT07218432","title":"A Window of Opportunity Pilot Study: TheraBionic P1 Device for Patients With Resectable Early-stage Breast Cancer in a Neoadjuvant Setting","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02438904","publication_url":"https://clinicaltrials.gov/study/NCT02438904","title":"Compassionate Access of the Miltenyi Device for CD34+ Cell Selection","has_exemption":false,"start_date":"2015-05-06","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03793478","publication_url":"https://clinicaltrials.gov/study/NCT03793478","title":"A Phase 1/2, Multicenter, Dose-Escalating Study To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy Of Quizartinib Administered in Combination With Re-Induction Chemotherapy, and as a Single-Agent Continuation Therapy, in Pediatric Relapsed/Refractory AML Subjects Aged 1 Month to <18 Years (and Young Adults Aged up to 21 Years) With FLT3-ITD Mutations","has_exemption":false,"start_date":"2018-08-15","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995562","publication_url":"https://clinicaltrials.gov/study/NCT04995562","title":"Use of Hyperpolarized 129Xe MR Lung Imaging in Infants","has_exemption":false,"start_date":"2020-05-06","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05333458","publication_url":"https://clinicaltrials.gov/study/NCT05333458","title":"A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05313165","publication_url":"https://clinicaltrials.gov/study/NCT05313165","title":"Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial","has_exemption":false,"start_date":"2022-12-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"LimFlow, Inc.","sponsor_slug":"limflow-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023329","publication_url":"https://clinicaltrials.gov/study/NCT06023329","title":"Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery","has_exemption":false,"start_date":"2023-01-03","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05524064","publication_url":"https://clinicaltrials.gov/study/NCT05524064","title":"FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax","has_exemption":false,"start_date":"2023-03-08","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05331170","publication_url":"https://clinicaltrials.gov/study/NCT05331170","title":"Epigenetic Mechanism Reprogramming Mucosal Anti-viral Immunity in Allergic Asthma VIRAL MUCOSAL REPROGRAMMING","has_exemption":false,"start_date":"2023-04-27","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Medical Branch, Galveston","sponsor_slug":"the-university-of-texas-medical-branch-galveston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669027","publication_url":"https://clinicaltrials.gov/study/NCT05669027","title":"Effective Self-Management of Chronic Pain With mHealth Neurofeedback","has_exemption":false,"start_date":"2023-10-02","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04808427","publication_url":"https://clinicaltrials.gov/study/NCT04808427","title":"Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation","has_exemption":false,"start_date":"2023-11-20","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938036","publication_url":"https://clinicaltrials.gov/study/NCT05938036","title":"PUERTA: A P2A Multi-center, Randomized, Double-blind, Placebo-controlled Study Assessing Safety and Efficacy of the eNAMPT Targeting mAb ALT-100 in Moderate/Severe ARDS/VILI Patients","has_exemption":false,"start_date":"2023-12-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Aqualung Therapeutics Corp.","sponsor_slug":"aqualung-therapeutics-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593497","publication_url":"https://clinicaltrials.gov/study/NCT05593497","title":"Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer With PTEN Loss","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377696","publication_url":"https://clinicaltrials.gov/study/NCT06377696","title":"Neuro-Oncology Anywhere: Deploying Mayo Clinic's Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin on Cognition and Quality of Life in Patients With History of Cranial Radiation","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524414","publication_url":"https://clinicaltrials.gov/study/NCT06524414","title":"A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Infants","has_exemption":false,"start_date":"2024-07-25","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06308588","publication_url":"https://clinicaltrials.gov/study/NCT06308588","title":"Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2024-08-05","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06548412","publication_url":"https://clinicaltrials.gov/study/NCT06548412","title":"CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers","has_exemption":false,"start_date":"2025-01-22","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915727","publication_url":"https://clinicaltrials.gov/study/NCT06915727","title":"Pafolacianine for Localization of Pediatric Extracranial Solid Tumors","has_exemption":false,"start_date":"2025-04-15","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06424067","publication_url":"https://clinicaltrials.gov/study/NCT06424067","title":"A Phase II Study of Fingolimod in Patients With Non-Small Cell and Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06627751","publication_url":"https://clinicaltrials.gov/study/NCT06627751","title":"Phase II Clinical Trial of Mezigdomide/Carfilzomib/Dexamethasone (MeziKD) in Patients With Relapsed or Refractory Multiple Myeloma (MM) With Extramedullary Disease (EMD)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06928766","publication_url":"https://clinicaltrials.gov/study/NCT06928766","title":"Effects of Eszopiclone and Lemborexant in People With Obstructive Sleep Apnoea (OSA) With a Low Arousal Threshold Who Have Difficulty Maintaining or Falling Asleep (ELOSA): A Double-blind, Placebo-controlled, Randomised, Trial.","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Flinders University","sponsor_slug":"flinders-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06600698","publication_url":"https://clinicaltrials.gov/study/NCT06600698","title":"Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)","has_exemption":false,"start_date":"2025-05-07","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834607","publication_url":"https://clinicaltrials.gov/study/NCT06834607","title":"Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Akhilesh Jain","sponsor_slug":"akhilesh-jain","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943534","publication_url":"https://clinicaltrials.gov/study/NCT06943534","title":"Omalizumab Weight-Based Dosing Efficacy Trial","has_exemption":false,"start_date":"2025-07-03","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513792","publication_url":"https://clinicaltrials.gov/study/NCT07513792","title":"The Impact of a 3D Imaging Visualization Tool for Orthodontic Treatment With Aligners in Reducing Periodontal Recession Occurrence","has_exemption":false,"start_date":"2025-09-04","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Liege","sponsor_slug":"university-of-liege","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224971","publication_url":"https://clinicaltrials.gov/study/NCT07224971","title":"Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy","has_exemption":false,"start_date":"2025-12-02","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Liza Villaruz, MD","sponsor_slug":"liza-villaruz-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217405","publication_url":"https://clinicaltrials.gov/study/NCT07217405","title":"Low-Dose Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285057","publication_url":"https://clinicaltrials.gov/study/NCT07285057","title":"Diagnostic Utility of rhPSMA-7.3 (18F) PET /CT Imaging in Patients With Prostate Cancer on Active Surveillance","has_exemption":false,"start_date":"2026-02-10","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071961","publication_url":"https://clinicaltrials.gov/study/NCT07071961","title":"Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]","has_exemption":false,"start_date":"2026-02-11","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06751992","publication_url":"https://clinicaltrials.gov/study/NCT06751992","title":"Neurocognitive Function Changes With Once-Daily Extended-Release Tacrolimus (Envarsus XR) Conversion Compared to Twice-Daily Immediate Release Tacrolimus Maintenance Among Older Kidney Transplant Recipients","has_exemption":false,"start_date":"2026-03-17","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431216","publication_url":"https://clinicaltrials.gov/study/NCT07431216","title":"A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Starlight Therapeutics Inc.","sponsor_slug":"starlight-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482423","publication_url":"https://clinicaltrials.gov/study/NCT07482423","title":"A Phase I/II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of XVIE Injected Intradermally in Patients With Androgenetic Alopecia","has_exemption":false,"start_date":"2026-05-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Restore Biologics Holdings, Inc. dba Xtressé","sponsor_slug":"restore-biologics-holdings-inc-dba-xtresse","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943664","publication_url":"https://clinicaltrials.gov/study/NCT06943664","title":"Phase II Trial: Photoimmunotherapy and Anti-PD1 in Patients With Refractory Inoperable and Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04381897","publication_url":"https://clinicaltrials.gov/study/NCT04381897","title":"Use of N-Acetylcysteine (NAC) in the Treatment of Repetitive Behaviors (RB) and Self-Injurious Behaviors (SIB) in Cornelia de Lange Syndrome: A Randomized Double-Blind Placebo-Controlled Pilot Study","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-05-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05362292","publication_url":"https://clinicaltrials.gov/study/NCT05362292","title":"Cognitive, Urinary, and Functional Trajectories of Older Women Using Pharmacologic Treatment Strategies for Urgency Incontinence","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06807268","publication_url":"https://clinicaltrials.gov/study/NCT06807268","title":"A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2025-07-24","completion_date":"2027-05-02","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07139951","publication_url":"https://clinicaltrials.gov/study/NCT07139951","title":"Prophylactic Hyperthermic IntraperitOneal Chemotherapy (p-HIPEC) for pRevention of perItONeal Recurrence in Gastric Cancer: MC240402 (HORIZON) Trial","has_exemption":false,"start_date":"2025-12-03","completion_date":"2027-05-03","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02628067","publication_url":"https://clinicaltrials.gov/study/NCT02628067","title":"A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)","has_exemption":false,"start_date":"2015-12-18","completion_date":"2027-05-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06428396","publication_url":"https://clinicaltrials.gov/study/NCT06428396","title":"A Phase 2, Randomized, Active-controlled, Open-label, Multicenter Study of Belzutifan Plus Fulvestrant in Participants With Estrogen Receptor Positive, HER2 Negative Unresectable Locally Advanced or Metastic Breast Cancer After Progression on Previous Endocrine Therapy (LITESPARK-029)","has_exemption":false,"start_date":"2024-11-27","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827054","publication_url":"https://clinicaltrials.gov/study/NCT06827054","title":"Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-05-05","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04329039","publication_url":"https://clinicaltrials.gov/study/NCT04329039","title":"Randomized Control Trial Comparing Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics","has_exemption":false,"start_date":"2020-11-17","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05063162","publication_url":"https://clinicaltrials.gov/study/NCT05063162","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)","has_exemption":false,"start_date":"2022-02-02","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06141473","publication_url":"https://clinicaltrials.gov/study/NCT06141473","title":"Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis","has_exemption":false,"start_date":"2023-12-13","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06138639","publication_url":"https://clinicaltrials.gov/study/NCT06138639","title":"A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)","has_exemption":false,"start_date":"2024-05-06","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Solid Biosciences Inc.","sponsor_slug":"solid-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465913","publication_url":"https://clinicaltrials.gov/study/NCT07465913","title":"Outcomes of Direct Selective Laser Trabeculoplasty With the Post-treatment Addition of Combination Netarsudil and Latanoprost vs Latonoprost Monotherapy","has_exemption":false,"start_date":"2026-05-06","completion_date":"2027-05-06","has_results":false,"results_due":false,"sponsor_name":"Eye Centers of Southeast Texas","sponsor_slug":"eye-centers-of-southeast-texas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03229200","publication_url":"https://clinicaltrials.gov/study/NCT03229200","title":"Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials.","has_exemption":false,"start_date":"2017-05-22","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Pharmacyclics Switzerland GmbH","sponsor_slug":"pharmacyclics-switzerland-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06074588","publication_url":"https://clinicaltrials.gov/study/NCT06074588","title":"A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations","has_exemption":false,"start_date":"2023-11-12","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498010","publication_url":"https://clinicaltrials.gov/study/NCT07498010","title":"The Role of Doxycycline in the Management of Postoperative Seromas: A Pilot Study","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-05-10","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06094010","publication_url":"https://clinicaltrials.gov/study/NCT06094010","title":"A Phase IIIb Multicenter, Single-Arm, Open-Label Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Patients With Influenza and Transmission of Influenza to Household Contacts","has_exemption":false,"start_date":"2023-11-22","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05726383","publication_url":"https://clinicaltrials.gov/study/NCT05726383","title":"MISTOSUS: Iscador® P (Mistletoe) Immunotherapy To Improve Event Free Survival In Patients With Relapsed Osteosarcoma After Resection Of Pulmonary Metastases","has_exemption":false,"start_date":"2024-05-14","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220642","publication_url":"https://clinicaltrials.gov/study/NCT07220642","title":"Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-05-11","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411158","publication_url":"https://clinicaltrials.gov/study/NCT06411158","title":"Training for Urinary Leakage Improvement After Pregnancy","has_exemption":false,"start_date":"2024-11-12","completion_date":"2027-05-12","has_results":false,"results_due":false,"sponsor_name":"NICHD Pelvic Floor Disorders Network","sponsor_slug":"nichd-pelvic-floor-disorders-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220759","publication_url":"https://clinicaltrials.gov/study/NCT07220759","title":"Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity and Type 2 Diabetes","has_exemption":false,"start_date":"2025-11-05","completion_date":"2027-05-12","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327114","publication_url":"https://clinicaltrials.gov/study/NCT05327114","title":"Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2022-09-23","completion_date":"2027-05-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230224","publication_url":"https://clinicaltrials.gov/study/NCT06230224","title":"A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, Versus Standard of Care Therapy in Participants With Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)","has_exemption":false,"start_date":"2024-02-15","completion_date":"2027-05-14","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455449","publication_url":"https://clinicaltrials.gov/study/NCT06455449","title":"A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)","has_exemption":false,"start_date":"2024-06-20","completion_date":"2027-05-14","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05343013","publication_url":"https://clinicaltrials.gov/study/NCT05343013","title":"TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy","has_exemption":false,"start_date":"2022-06-06","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445062","publication_url":"https://clinicaltrials.gov/study/NCT06445062","title":"A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors","has_exemption":false,"start_date":"2024-05-24","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06448026","publication_url":"https://clinicaltrials.gov/study/NCT06448026","title":"Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06836609","publication_url":"https://clinicaltrials.gov/study/NCT06836609","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Two Doses of ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)","has_exemption":false,"start_date":"2025-04-28","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282639","publication_url":"https://clinicaltrials.gov/study/NCT07282639","title":"Development and Evaluation of App-Based Certified Diabetes Education (AB-CDE) Therapy for People Living With T1D Using MDI","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467720","publication_url":"https://clinicaltrials.gov/study/NCT07467720","title":"Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05454566","publication_url":"https://clinicaltrials.gov/study/NCT05454566","title":"A Single Dose Escalation Study of Intra-Articular ICM-203 in Subjects With Kellgren-Lawrence Grade 2 or Grade 3 Osteoarthritis of the Knee","has_exemption":false,"start_date":"2026-11-15","completion_date":"2027-05-15","has_results":false,"results_due":false,"sponsor_name":"ICM Co. Ltd.","sponsor_slug":"icm-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06912646","publication_url":"https://clinicaltrials.gov/study/NCT06912646","title":"An Evaluation of the Effect of the Erchonia® EVRL™ for Prescription Home Use Application in Providing Temporary Relief From Idiopathic Peripheral Neuropathy Foot Pain","has_exemption":false,"start_date":"2025-05-01","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Erchonia Corporation","sponsor_slug":"erchonia-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979362","publication_url":"https://clinicaltrials.gov/study/NCT06979362","title":"Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979375","publication_url":"https://clinicaltrials.gov/study/NCT06979375","title":"Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-05-16","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04322370","publication_url":"https://clinicaltrials.gov/study/NCT04322370","title":"Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries","has_exemption":false,"start_date":"2020-08-21","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06290128","publication_url":"https://clinicaltrials.gov/study/NCT06290128","title":"A Phase 3, Double-blind, Placebo-controlled Study Evaluating Efficacy and Safety of Riliprubart in Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy","has_exemption":false,"start_date":"2024-07-12","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06647407","publication_url":"https://clinicaltrials.gov/study/NCT06647407","title":"A Parallel-group Prevention, Phase II, Partially Blinded, Multi-stage Study to Investigate the Immunogenicity and Safety of Pentavalent Meningococcal ABCYW Vaccine Formulations Compared With Licensed Meningococcal Vaccines When Administered Alone in Healthy Children (2 to 9 Years of Age) or Concomitantly With Routine Pediatric Vaccines in Toddlers (12 to 15 Months of Age) and Infants (2 Months of Age).","has_exemption":false,"start_date":"2024-11-05","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736041","publication_url":"https://clinicaltrials.gov/study/NCT06736041","title":"A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers","has_exemption":false,"start_date":"2024-12-18","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220577","publication_url":"https://clinicaltrials.gov/study/NCT07220577","title":"A Multicenter, Randomized, Participant- and Investigator -Blinded, Placebo-controlled, Phase 2a Study to Assess the Efficacy, Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-11-10","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213778","publication_url":"https://clinicaltrials.gov/study/NCT07213778","title":"A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277660","publication_url":"https://clinicaltrials.gov/study/NCT07277660","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482787","publication_url":"https://clinicaltrials.gov/study/NCT07482787","title":"A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-05-17","has_results":false,"results_due":false,"sponsor_name":"Paradigm Therapeutics","sponsor_slug":"paradigm-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660667","publication_url":"https://clinicaltrials.gov/study/NCT06660667","title":"A Phase 1/2 Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR402663 in Participants With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671483","publication_url":"https://clinicaltrials.gov/study/NCT06671483","title":"A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671496","publication_url":"https://clinicaltrials.gov/study/NCT06671496","title":"A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)","has_exemption":false,"start_date":"2025-03-10","completion_date":"2027-05-18","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04803201","publication_url":"https://clinicaltrials.gov/study/NCT04803201","title":"A Randomized Phase II Study of CHO(E)P vs CC-486-CHO(E)P vs Duvelisib-CHO(E)P in Previously Untreated CD30 Negative Peripheral T-Cell Lymphomas","has_exemption":false,"start_date":"2021-10-08","completion_date":"2027-05-19","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05624554","publication_url":"https://clinicaltrials.gov/study/NCT05624554","title":"A Phase 3, Randomized Study to Compare the Efficacy and Safety of Nemtabrutinib Versus Chemoimmunotherapy for Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Without TP53 Aberrations","has_exemption":false,"start_date":"2023-03-16","completion_date":"2027-05-19","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01473628","publication_url":"https://clinicaltrials.gov/study/NCT01473628","title":"Randomized Trial of Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II","has_exemption":false,"start_date":"2013-05-20","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03958877","publication_url":"https://clinicaltrials.gov/study/NCT03958877","title":"An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension","has_exemption":false,"start_date":"2019-10-18","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465329","publication_url":"https://clinicaltrials.gov/study/NCT06465329","title":"A Randomized Phase 2 Platform Study to Evaluate Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for the Perioperative Treatment of Patients With Resectable Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-11-18","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311227","publication_url":"https://clinicaltrials.gov/study/NCT06311227","title":"A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia","has_exemption":false,"start_date":"2024-12-16","completion_date":"2027-05-20","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05132504","publication_url":"https://clinicaltrials.gov/study/NCT05132504","title":"Phase II Study of Neoadjuvant Folfirinox Chemotherapy Followed by Pembrolizumab Followed by Surgery for Patients With Localized, Resectable Adenocarcinoma of the Pancreas","has_exemption":false,"start_date":"2022-08-31","completion_date":"2027-05-21","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227831","publication_url":"https://clinicaltrials.gov/study/NCT07227831","title":"A Phase 2 Study of TheraBionic P1 Device for Patients With Metastatic Hormone Positive Breast Cancer Post Endocrine Therapy","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-05-22","has_results":false,"results_due":false,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05886634","publication_url":"https://clinicaltrials.gov/study/NCT05886634","title":"A Phase II Study of Adenosine Receptor (A2A and A2B) Inhibition (AB928) in Combination With Anti-PD-1 Therapy (AB122) in Patients With Advanced Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2023-05-23","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049159","publication_url":"https://clinicaltrials.gov/study/NCT07049159","title":"A Two-stage, Phase 2b, Randomized, Double-blind, Placebo-controlled Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Disease Delivered to Healthy Adults Ages 18 to 50 Years Old","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"Eveliqure Biotechnologies GmbH","sponsor_slug":"eveliqure-biotechnologies-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07311564","publication_url":"https://clinicaltrials.gov/study/NCT07311564","title":"A Phase 2, Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate Efficacy and Safety of LAD603 in Adult Subjects With Severe to Very Severe Alopecia Areata","has_exemption":false,"start_date":"2025-12-17","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"Almirall, S.A.","sponsor_slug":"almirall-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07451184","publication_url":"https://clinicaltrials.gov/study/NCT07451184","title":"Symptomology Changes With Systane PRO PF Versus Thealoz Duo","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-05-23","has_results":false,"results_due":false,"sponsor_name":"University of Waterloo","sponsor_slug":"university-of-waterloo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06157567","publication_url":"https://clinicaltrials.gov/study/NCT06157567","title":"Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System","has_exemption":false,"start_date":"2022-05-24","completion_date":"2027-05-24","has_results":false,"results_due":false,"sponsor_name":"Candela Corporation","sponsor_slug":"candela-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05865028","publication_url":"https://clinicaltrials.gov/study/NCT05865028","title":"Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia","has_exemption":false,"start_date":"2023-05-24","completion_date":"2027-05-24","has_results":false,"results_due":false,"sponsor_name":"Elizabeth J Franzmann","sponsor_slug":"elizabeth-j-franzmann","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222917","publication_url":"https://clinicaltrials.gov/study/NCT07222917","title":"A Phase IIb, Randomised, Multicentre, Double-Blind Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.","has_exemption":false,"start_date":"2025-12-05","completion_date":"2027-05-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05067140","publication_url":"https://clinicaltrials.gov/study/NCT05067140","title":"A Phase 1/2 Open-Label, Dose-Escalation and Cohort Expansion Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARV-766 Monotherapy and in Combination With Abiraterone in Patients With Metastatic Prostate Cancer","has_exemption":false,"start_date":"2021-09-02","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519878","publication_url":"https://clinicaltrials.gov/study/NCT05519878","title":"Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers","has_exemption":false,"start_date":"2022-11-29","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06327113","publication_url":"https://clinicaltrials.gov/study/NCT06327113","title":"A Phase 2 Randomized Study Comparing Subcutaneous Tumescent Antibiotic Administration With Standard of Care for the Treatment of Chronic Wounds","has_exemption":false,"start_date":"2024-05-17","completion_date":"2027-05-25","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453213","publication_url":"https://clinicaltrials.gov/study/NCT06453213","title":"Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy","has_exemption":false,"start_date":"2024-10-14","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"SK Life Science, Inc.","sponsor_slug":"sk-life-science-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782490","publication_url":"https://clinicaltrials.gov/study/NCT06782490","title":"A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of Three Doses of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Multiple Sclerosis (BALANCE-MSS-1)","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-05-26","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05173987","publication_url":"https://clinicaltrials.gov/study/NCT05173987","title":"A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab Versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting (KEYNOTE-C93/GOG-3064/ENGOT-en15)","has_exemption":false,"start_date":"2022-02-03","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06531941","publication_url":"https://clinicaltrials.gov/study/NCT06531941","title":"An Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism Who Completed the 12-Week Treatment Period in the Phase 2 Study, MBX-2H1002 Study (Avail-Ext)","has_exemption":false,"start_date":"2024-10-31","completion_date":"2027-05-27","has_results":false,"results_due":false,"sponsor_name":"MBX Biosciences","sponsor_slug":"mbx-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04644068","publication_url":"https://clinicaltrials.gov/study/NCT04644068","title":"A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2020-11-12","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04879862","publication_url":"https://clinicaltrials.gov/study/NCT04879862","title":"Inter-System Closed-Loop Control of Locomotor and Bladder Function in Individuals With Acute Spinal Cord Injury","has_exemption":false,"start_date":"2022-04-04","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Claudia Angeli","sponsor_slug":"claudia-angeli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06016855","publication_url":"https://clinicaltrials.gov/study/NCT06016855","title":"Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2024-05-31","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449001","publication_url":"https://clinicaltrials.gov/study/NCT06449001","title":"A Phase 3 Open-Label Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With Paroxysmal Nocturnal Hemoglobinuria Who Have Clinically Significant Extravascular Hemolysis","has_exemption":false,"start_date":"2025-08-11","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209761","publication_url":"https://clinicaltrials.gov/study/NCT07209761","title":"A Phase 3, Randomized, Open-label, Multicenter Trial to Evaluate the Efficacy, Safety, and Tolerability of 4-month and 6-month Quabodepistat-containing Regimens for Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis","has_exemption":false,"start_date":"2025-10-16","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465224","publication_url":"https://clinicaltrials.gov/study/NCT07465224","title":"A Randomized, Double-blind, Placebo-controlled Study Investigating the Effect of ALN-4324 on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07311876","publication_url":"https://clinicaltrials.gov/study/NCT07311876","title":"Clinical Lymphedema Evaluation - Advancing Reconstruction of Head and Neck Lymphatics With Symani","has_exemption":false,"start_date":"2026-04-28","completion_date":"2027-05-28","has_results":false,"results_due":false,"sponsor_name":"MMI (Medical Microinstruments, Inc.)","sponsor_slug":"mmi-medical-microinstruments-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05284747","publication_url":"https://clinicaltrials.gov/study/NCT05284747","title":"EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction","has_exemption":false,"start_date":"2022-10-26","completion_date":"2027-05-29","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07026877","publication_url":"https://clinicaltrials.gov/study/NCT07026877","title":"A Prospective, Multicenter, Non-Blinded, Non-Randomized Pivotal Study of the Fenestrated TREO Stent-Graft System in Subjects With Abdominal Aortic Aneurysms Requiring a Fenestrated Graft and Suitable for Endovascular Repair","has_exemption":false,"start_date":"2025-11-18","completion_date":"2027-05-29","has_results":false,"results_due":false,"sponsor_name":"Bolton Medical","sponsor_slug":"bolton-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03242642","publication_url":"https://clinicaltrials.gov/study/NCT03242642","title":"Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial","has_exemption":false,"start_date":"2017-10-23","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04910022","publication_url":"https://clinicaltrials.gov/study/NCT04910022","title":"A Phase I/II Combination Study of NMS-03305293 and Temozolomide in Adult Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2021-12-01","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Nerviano Medical Sciences","sponsor_slug":"nerviano-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05786417","publication_url":"https://clinicaltrials.gov/study/NCT05786417","title":"A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER","has_exemption":false,"start_date":"2023-05-10","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06078709","publication_url":"https://clinicaltrials.gov/study/NCT06078709","title":"Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal/Gastroesophageal Junction Adenocarcinoma (PHOX)","has_exemption":false,"start_date":"2023-11-20","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06436612","publication_url":"https://clinicaltrials.gov/study/NCT06436612","title":"Phase II Study of Magnetic Resonance Image and Computed Tomography-Guided Stereotactic Body Radiation Therapy for Abdominopelvic Sarcomas (MARS Trial)","has_exemption":false,"start_date":"2024-05-30","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561087","publication_url":"https://clinicaltrials.gov/study/NCT06561087","title":"Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions","has_exemption":false,"start_date":"2025-02-27","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06476132","publication_url":"https://clinicaltrials.gov/study/NCT06476132","title":"Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients: A Randomized, Multicenter, Double Blind, Placebo-Controlled Trial (CTOT-47)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06916286","publication_url":"https://clinicaltrials.gov/study/NCT06916286","title":"A Prospective, Randomized, Multi-center Trial Evaluating the Effect of Surgical Drain Securement on Patient Quality of Life and Postoperative Drain-related Complications","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982820","publication_url":"https://clinicaltrials.gov/study/NCT06982820","title":"A Prospective, Randomized, Double-blind, Controlled Study to Produce Guidelines for Integrating Prism for MDD Therapy (Reward System [RS] Upregulation) and to Demonstrate Its Superiority Over Sham Therapy","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"GrayMatters Health Ltd.","sponsor_slug":"graymatters-health-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04480619","publication_url":"https://clinicaltrials.gov/study/NCT04480619","title":"Safety and Efficacy of Ga-68-IAC Positron Emission Tomography (PET/CT) for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients.","has_exemption":false,"start_date":"2025-10-30","completion_date":"2027-05-30","has_results":false,"results_due":false,"sponsor_name":"Advanced Imaging Projects, LLC","sponsor_slug":"advanced-imaging-projects-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00107289","publication_url":"https://clinicaltrials.gov/study/NCT00107289","title":"Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors","has_exemption":false,"start_date":"2006-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01864109","publication_url":"https://clinicaltrials.gov/study/NCT01864109","title":"A Phase II Trial of Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma","has_exemption":false,"start_date":"2013-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02656511","publication_url":"https://clinicaltrials.gov/study/NCT02656511","title":"Immediate Initiation of Antiretroviral Therapy During Acute HIV Infection","has_exemption":false,"start_date":"2015-12-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02727803","publication_url":"https://clinicaltrials.gov/study/NCT02727803","title":"Personalized NK Cell Therapy in CBT","has_exemption":false,"start_date":"2016-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03128879","publication_url":"https://clinicaltrials.gov/study/NCT03128879","title":"A Phase II Study of Venetoclax (ABT-199) Consolidation for Patients Currently Receiving Ibrutinib or Acalabrutinib for High-risk CLL","has_exemption":false,"start_date":"2017-06-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03110926","publication_url":"https://clinicaltrials.gov/study/NCT03110926","title":"Induction Chemotherapy for Locally Advanced Esophageal Cancer: A Phase II Study","has_exemption":false,"start_date":"2017-06-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03233399","publication_url":"https://clinicaltrials.gov/study/NCT03233399","title":"Modulating Movement Intention Via Cortical Stimulation in Healthy Subjects and Patients With Psychogenic Movement Disorders and Non-epileptic Seizures","has_exemption":false,"start_date":"2017-07-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03384836","publication_url":"https://clinicaltrials.gov/study/NCT03384836","title":"A Phase Ib/II Study of Propranolol With Fixed-Dose Pembrolizumab in Patients With Unresectable Stage III and Stage IV Melanoma","has_exemption":false,"start_date":"2018-01-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03667651","publication_url":"https://clinicaltrials.gov/study/NCT03667651","title":"THE PEBBLES STUDY: A Randomised Controlled Trial to Prevent Eczema, Food Allergy and Sensitisation Using a Skin Barrier Improvement Strategy","has_exemption":false,"start_date":"2018-03-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Melbourne","sponsor_slug":"university-of-melbourne","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03898479","publication_url":"https://clinicaltrials.gov/study/NCT03898479","title":"A Multicenter, Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata","has_exemption":false,"start_date":"2019-04-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries, Inc.","sponsor_slug":"sun-pharmaceutical-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999994","publication_url":"https://clinicaltrials.gov/study/NCT05999994","title":"CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research","has_exemption":false,"start_date":"2020-01-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04293185","publication_url":"https://clinicaltrials.gov/study/NCT04293185","title":"A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the BB305 Lentiviral Vector in Subjects With Sickle Cell Disease","has_exemption":false,"start_date":"2020-02-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Genetix Biotherapeutics Inc.","sponsor_slug":"genetix-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04420702","publication_url":"https://clinicaltrials.gov/study/NCT04420702","title":"Diffusion Basis Spectrum Imaging of the Prostate: A Virtual Biopsy to Accurately Diagnose Prostate Cancer","has_exemption":false,"start_date":"2020-02-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04419519","publication_url":"https://clinicaltrials.gov/study/NCT04419519","title":"Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease by Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL/SLL Patients","has_exemption":false,"start_date":"2020-05-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04176718","publication_url":"https://clinicaltrials.gov/study/NCT04176718","title":"A Phase II Study of Daratumumab With Weekly Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed and Refractory Multiple Myeloma","has_exemption":false,"start_date":"2020-05-18","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Andrew Yee, MD","sponsor_slug":"andrew-yee-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04322955","publication_url":"https://clinicaltrials.gov/study/NCT04322955","title":"Cyto-KIK; TRIAL (CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy (Nivolumab) and Targeted Kinase Inhibition (Cabozantinib)","has_exemption":false,"start_date":"2020-06-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mark Stein","sponsor_slug":"mark-stein","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04485286","publication_url":"https://clinicaltrials.gov/study/NCT04485286","title":"Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury","has_exemption":false,"start_date":"2020-07-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04736173","publication_url":"https://clinicaltrials.gov/study/NCT04736173","title":"Official Title: A Phase 2 Study to Evaluate Zimberelimab (AB122) Combined With AB154 in Front-Line, PD-L1-High, Locally Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-02-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04721132","publication_url":"https://clinicaltrials.gov/study/NCT04721132","title":"An Open-Label, Phase II, Pre-Operative Study of Atezolizumab Plus Bevacizumab for Resectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2021-02-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04775485","publication_url":"https://clinicaltrials.gov/study/NCT04775485","title":"FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients With RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors","has_exemption":true,"start_date":"2021-04-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Day One Biopharmaceuticals, Inc.","sponsor_slug":"day-one-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04699604","publication_url":"https://clinicaltrials.gov/study/NCT04699604","title":"A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma","has_exemption":false,"start_date":"2021-04-28","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Bridgette Jones","sponsor_slug":"bridgette-jones","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04891289","publication_url":"https://clinicaltrials.gov/study/NCT04891289","title":"A Randomized Phase II Study of Systemic Chemotherapy With or Without HAI FUDR/Dexamethasone in Patients With Unresectable Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2021-05-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04957615","publication_url":"https://clinicaltrials.gov/study/NCT04957615","title":"A Phase II Clinical Trial to Investigate ARID1A Mutation and CXCL13 Expression in the Pre-Treatment Tumor Samples as a Combinatorial Predictive Biomarker for Immune Checkpoint Therapy in Metastatic Solid Tumors","has_exemption":false,"start_date":"2021-09-21","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833140","publication_url":"https://clinicaltrials.gov/study/NCT04833140","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","has_exemption":false,"start_date":"2021-12-02","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04982757","publication_url":"https://clinicaltrials.gov/study/NCT04982757","title":"Accelerated TMS for Depression and OCD","has_exemption":false,"start_date":"2021-12-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04599504","publication_url":"https://clinicaltrials.gov/study/NCT04599504","title":"Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)","has_exemption":false,"start_date":"2022-01-02","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04605081","publication_url":"https://clinicaltrials.gov/study/NCT04605081","title":"Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Maintenance Treatment (Stage 2a)","has_exemption":false,"start_date":"2022-01-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05138575","publication_url":"https://clinicaltrials.gov/study/NCT05138575","title":"SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial","has_exemption":false,"start_date":"2022-01-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04380740","publication_url":"https://clinicaltrials.gov/study/NCT04380740","title":"A Randomized Double-Blind Trial of Abatacept Extended Dosing Versus Abatacept Short-term Dosing for Graft Versus Host Disease Prophylaxis: \"ABA3\"","has_exemption":false,"start_date":"2022-03-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384496","publication_url":"https://clinicaltrials.gov/study/NCT05384496","title":"Phase 2 Study of Axitinib + PD-1 Blockade in Mucosal Melanoma With Pilot Addition of Stereotactic Body Radiotherapy or Ipilimumab in Select Progressors","has_exemption":false,"start_date":"2022-05-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05081128","publication_url":"https://clinicaltrials.gov/study/NCT05081128","title":"A Placebo-Controlled Efficacy in iNPH Shunting (PENS) Trial","has_exemption":false,"start_date":"2022-05-18","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05393804","publication_url":"https://clinicaltrials.gov/study/NCT05393804","title":"Feasibility Trial of Autologous Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy Using Ide-Cel for Multiple Myeloma Patients Status Post Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2022-05-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379985","publication_url":"https://clinicaltrials.gov/study/NCT05379985","title":"A Multicenter Open-Label Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS","has_exemption":false,"start_date":"2022-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03828201","publication_url":"https://clinicaltrials.gov/study/NCT03828201","title":"Prospective, Randomized, Partially Blinded, Phase 2 Study of the Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine for Treatment of Patients With MDR-TB","has_exemption":false,"start_date":"2022-06-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston University","sponsor_slug":"boston-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05429632","publication_url":"https://clinicaltrials.gov/study/NCT05429632","title":"Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT","has_exemption":false,"start_date":"2022-06-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Priothera SAS","sponsor_slug":"priothera-sas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05042102","publication_url":"https://clinicaltrials.gov/study/NCT05042102","title":"The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder","has_exemption":false,"start_date":"2022-08-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Connecticut Healthcare System","sponsor_slug":"va-connecticut-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254327","publication_url":"https://clinicaltrials.gov/study/NCT05254327","title":"A Randomized Phase 2 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With and Without BMX-001 as Part of Total Neoadjuvant Therapy in Patients With Newly Diagnosed Locally Advanced Rectal Adenocarcinoma","has_exemption":false,"start_date":"2022-08-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318417","publication_url":"https://clinicaltrials.gov/study/NCT05318417","title":"A Post-approval, Prospective, Nonrandomized, Single-arm Multicenter Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness","has_exemption":false,"start_date":"2022-08-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Cochlear","sponsor_slug":"cochlear","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05427708","publication_url":"https://clinicaltrials.gov/study/NCT05427708","title":"Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety: A Randomized Clinical Trial","has_exemption":false,"start_date":"2022-08-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05272254","publication_url":"https://clinicaltrials.gov/study/NCT05272254","title":"Povidone Iodine Efficacy Study","has_exemption":false,"start_date":"2022-09-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05456321","publication_url":"https://clinicaltrials.gov/study/NCT05456321","title":"tDCS and Cognitive Training as a Neurodevelopmental Intervention in FASD","has_exemption":false,"start_date":"2022-11-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05378347","publication_url":"https://clinicaltrials.gov/study/NCT05378347","title":"Endurant Stent Graft System vs Excluder Endoprothesis: A Global, Prospective, Randomized Clinical Trial in Sac Regression","has_exemption":false,"start_date":"2023-01-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111729","publication_url":"https://clinicaltrials.gov/study/NCT06111729","title":"Habit Awareness Device for Treatment of Onychophagia","has_exemption":false,"start_date":"2023-01-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05375968","publication_url":"https://clinicaltrials.gov/study/NCT05375968","title":"Mechanism of Glucose-dependent Insulinotropic Polypeptide (GIP) on Splanchnic Venous Capacitance in Postural Tachycardia Syndrome","has_exemption":false,"start_date":"2023-02-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874855","publication_url":"https://clinicaltrials.gov/study/NCT06874855","title":"Lemborexant in Delayed Sleep Phase Syndrome","has_exemption":false,"start_date":"2023-03-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05562167","publication_url":"https://clinicaltrials.gov/study/NCT05562167","title":"The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF) -a Phase II Clinical Trial","has_exemption":false,"start_date":"2023-03-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05500963","publication_url":"https://clinicaltrials.gov/study/NCT05500963","title":"Reducing Fatigue in People With Multiple Sclerosis by Treatment With Transcutaneous Electrical Nerve Stimulation","has_exemption":false,"start_date":"2023-04-25","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Boulder","sponsor_slug":"university-of-colorado-boulder","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671861","publication_url":"https://clinicaltrials.gov/study/NCT05671861","title":"Design of a Low-Cost Therapeutic Device for Patients With Radiation-Related Trismus","has_exemption":false,"start_date":"2023-04-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794880","publication_url":"https://clinicaltrials.gov/study/NCT05794880","title":"Matched Unrelated Donor and Partially Matched Related Donor Peripheral Stem Cell Transplantation With Alpha/Beta T-Cell and B-Cell Depletion for Patients With Hematologic Malignancies With Targeted ATG Dosing Pilot Study, IDE 13641","has_exemption":false,"start_date":"2023-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05716516","publication_url":"https://clinicaltrials.gov/study/NCT05716516","title":"Phase II Study of Estradiol Therapy to Target ER-Mutant and ER-Wild-Type ER+ Metastatic or Advanced Breast Cancer","has_exemption":false,"start_date":"2023-05-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05295680","publication_url":"https://clinicaltrials.gov/study/NCT05295680","title":"A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).","has_exemption":false,"start_date":"2023-05-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Aparna Goel","sponsor_slug":"aparna-goel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589818","publication_url":"https://clinicaltrials.gov/study/NCT05589818","title":"A Phase II Study of the Effects of Pembrolizumab on Quality of Life for Patients With Treatment-Naïve, Advanced or Metastatic NSCLC and Poor Performance Status","has_exemption":false,"start_date":"2023-05-26","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05209165","publication_url":"https://clinicaltrials.gov/study/NCT05209165","title":"Semaglutide as Treatment of Overweight and Obese Individuals to Reduce Atrial Fibrillation Burden","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"San Francisco Veterans Affairs Medical Center","sponsor_slug":"san-francisco-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05881408","publication_url":"https://clinicaltrials.gov/study/NCT05881408","title":"A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP- 9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06231342","publication_url":"https://clinicaltrials.gov/study/NCT06231342","title":"Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion to Decrease the Risk of Postoperative Sore Throat: a Randomized Double-Blind Prospective Trial.","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05694871","publication_url":"https://clinicaltrials.gov/study/NCT05694871","title":"Official Title A Randomized Phase 2 Trial With a Safety Lead-In to Evaluate Palbociclib Versus Palbociclib and Cemiplimab for the Treatment of Advanced Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2023-06-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05845814","publication_url":"https://clinicaltrials.gov/study/NCT05845814","title":"A Phase 1/2 Randomized, Umbrella Study to Evaluate the Safety and Efficacy of Pembrolizumab Plus Enfortumab Vedotin (EV) in Combination With Investigational Agents Versus Pembrolizumab Plus EV, as First-Line Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04B","has_exemption":false,"start_date":"2023-06-23","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05853939","publication_url":"https://clinicaltrials.gov/study/NCT05853939","title":"Inducing and Measuring Visual-evoked Potential Plasticity in Humans With Repetitive Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801939","publication_url":"https://clinicaltrials.gov/study/NCT05801939","title":"Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2023-07-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05819866","publication_url":"https://clinicaltrials.gov/study/NCT05819866","title":"A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy","has_exemption":false,"start_date":"2023-07-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Minoryx Therapeutics, S.L.","sponsor_slug":"minoryx-therapeutics-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066645","publication_url":"https://clinicaltrials.gov/study/NCT06066645","title":"Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects With Open-angle Glaucoma or Ocular Hypertension","has_exemption":false,"start_date":"2023-09-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05816122","publication_url":"https://clinicaltrials.gov/study/NCT05816122","title":"MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect","has_exemption":false,"start_date":"2023-09-22","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ad scientiam","sponsor_slug":"ad-scientiam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05851976","publication_url":"https://clinicaltrials.gov/study/NCT05851976","title":"Duloxetine for Patients With Low Back Pain Who Fail to Improve With Oral NSAIDs. A Randomized Placebo-controlled Exploratory Study","has_exemption":false,"start_date":"2023-10-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06040320","publication_url":"https://clinicaltrials.gov/study/NCT06040320","title":"A Phase I/II Study of Frontline Therapy With Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)","has_exemption":false,"start_date":"2023-10-04","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06137274","publication_url":"https://clinicaltrials.gov/study/NCT06137274","title":"Phase 2 Trial of Adaptive Radiotherapy Boost for Head and Neck Squamous Cell Carcinomas","has_exemption":false,"start_date":"2023-12-14","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766371","publication_url":"https://clinicaltrials.gov/study/NCT05766371","title":"A Phase 2 Study of Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2023-12-15","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082518","publication_url":"https://clinicaltrials.gov/study/NCT06082518","title":"Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (PCS-HBOT Study)","has_exemption":false,"start_date":"2024-01-02","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06128915","publication_url":"https://clinicaltrials.gov/study/NCT06128915","title":"The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses","has_exemption":false,"start_date":"2024-01-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05903859","publication_url":"https://clinicaltrials.gov/study/NCT05903859","title":"Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169124","publication_url":"https://clinicaltrials.gov/study/NCT06169124","title":"A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination With Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor","has_exemption":false,"start_date":"2024-02-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06120140","publication_url":"https://clinicaltrials.gov/study/NCT06120140","title":"A Phase 2, Open-Label, Randomized Trial Evaluating the Impact of Enhanced Versus Standard Dermatologic Management on Selected Dermatologic Adverse Events Among Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC Treated First-Line With Amivantamab + Lazertinib","has_exemption":false,"start_date":"2024-02-16","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05483010","publication_url":"https://clinicaltrials.gov/study/NCT05483010","title":"Pilot Study of Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)","has_exemption":false,"start_date":"2024-02-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05701111","publication_url":"https://clinicaltrials.gov/study/NCT05701111","title":"Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress","has_exemption":false,"start_date":"2024-02-23","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003153","publication_url":"https://clinicaltrials.gov/study/NCT06003153","title":"GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH","has_exemption":false,"start_date":"2024-03-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06319027","publication_url":"https://clinicaltrials.gov/study/NCT06319027","title":"Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial (GABLE)","has_exemption":false,"start_date":"2024-04-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06338995","publication_url":"https://clinicaltrials.gov/study/NCT06338995","title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants With Chronic Rhinosinusitis With Nasal Polyps on Background Intranasal Corticosteroids","has_exemption":false,"start_date":"2024-04-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05880810","publication_url":"https://clinicaltrials.gov/study/NCT05880810","title":"Continuous Glucose Monitor Use for Mayo Clinic Advanced Care at Home Patients With Diabetes Mellitus","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214949","publication_url":"https://clinicaltrials.gov/study/NCT06214949","title":"Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) as a Treatment for Chronic Neck Pain","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06237868","publication_url":"https://clinicaltrials.gov/study/NCT06237868","title":"The Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Impulse Control Disorders in Parkinson's Disease Patients on Dopamine Replacement Therapy.","has_exemption":false,"start_date":"2024-05-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06249048","publication_url":"https://clinicaltrials.gov/study/NCT06249048","title":"A Phase 1/2, Open-label, Multi-center, First-in-human Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of STX-001 Delivered by Intratumoral Injection in Patients With Advanced Solid Tumors as a Monotherapy or in Combination With Pembrolizumab","has_exemption":false,"start_date":"2024-05-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Strand Therapeutics Inc.","sponsor_slug":"strand-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411821","publication_url":"https://clinicaltrials.gov/study/NCT06411821","title":"Phase 2 Trial of Ulixertinib for Patients With Histiocytic Neoplasms","has_exemption":false,"start_date":"2024-05-07","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364176","publication_url":"https://clinicaltrials.gov/study/NCT06364176","title":"Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411249","publication_url":"https://clinicaltrials.gov/study/NCT06411249","title":"A Phase 4, Multicenter, Prospective, Open-Label Study Describing the Efficacy and Safety of Belimumab Administered Subcutaneously in Adult Participants With Early Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2024-06-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06259006","publication_url":"https://clinicaltrials.gov/study/NCT06259006","title":"TREAT-SC: A Randomised, Double-Blinded, Placebo-Controlled Trial of Early, Short Course Oral Dexamethasone for the Treatment of Sydenham Chorea in Children","has_exemption":false,"start_date":"2024-06-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Starship Child Health, Te Toka Tumai Auckland","sponsor_slug":"starship-child-health-te-toka-tumai-auckland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06456580","publication_url":"https://clinicaltrials.gov/study/NCT06456580","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With an Open-label Extension Period to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-07-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vor Biopharma","sponsor_slug":"vor-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351111","publication_url":"https://clinicaltrials.gov/study/NCT06351111","title":"Vagus Nerve Stimulation (VNS) in Spinal Cord Injury (SCI) Adaptive Follow-On Study","has_exemption":false,"start_date":"2024-08-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06247098","publication_url":"https://clinicaltrials.gov/study/NCT06247098","title":"Sinus Augmentation Healing With Autogenous and Xenograft Mix Compared to Xenograft Alone","has_exemption":false,"start_date":"2024-09-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Tufts University","sponsor_slug":"tufts-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06325813","publication_url":"https://clinicaltrials.gov/study/NCT06325813","title":"ADHD PreSMA Response Inhibition Therapy","has_exemption":false,"start_date":"2024-09-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053814","publication_url":"https://clinicaltrials.gov/study/NCT06053814","title":"A Phase 1/2, First in Human, Multiple-dose, 2-part Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NS-050/NCNP-03 in Boys With Duchenne Muscular Dystrophy (DMD)","has_exemption":false,"start_date":"2024-09-18","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"NS Pharma, Inc.","sponsor_slug":"ns-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628908","publication_url":"https://clinicaltrials.gov/study/NCT06628908","title":"A Phase 3, Randomized, Double-blind, Placebo- and Active-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625060","publication_url":"https://clinicaltrials.gov/study/NCT06625060","title":"A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults","has_exemption":false,"start_date":"2024-10-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162715","publication_url":"https://clinicaltrials.gov/study/NCT06162715","title":"GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial","has_exemption":false,"start_date":"2024-10-30","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609577","publication_url":"https://clinicaltrials.gov/study/NCT06609577","title":"Personalized Ultrasound Guided Pacing of the External Diaphragm to Improve Outcomes in Patients Undergoing Invasive Mechanical Ventilation: a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-11-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Daishan Jiang","sponsor_slug":"daishan-jiang","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710288","publication_url":"https://clinicaltrials.gov/study/NCT06710288","title":"A Phase 2, Open-label, Single-arm Study Of Autologous Memory Cytokine Enriched Natural Killer (M-CENK) Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer","has_exemption":false,"start_date":"2024-11-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06537414","publication_url":"https://clinicaltrials.gov/study/NCT06537414","title":"A Phase 2b, Multi-centre, Randomized, Partially Placebo-controlled, Double-blind Study to Investigate the Safety and Efficacy of Sequential Therapy With Daplusiran/Tomligisiran Followed by Bepirovirsen in Participants With Chronic Hepatitis B Virus on Background Nucleos(t)Ide Analogue Therapy (B-United)","has_exemption":false,"start_date":"2024-11-11","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06191848","publication_url":"https://clinicaltrials.gov/study/NCT06191848","title":"Effect of Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Melbourne","sponsor_slug":"university-of-melbourne","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702449","publication_url":"https://clinicaltrials.gov/study/NCT06702449","title":"A Seamless Phase 1/2, Observer-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Safety and Immunogenicity of a UTI Vaccine When Administered to Adults 18 Through 64 Years of Age and Clinical Efficacy When Administered to Females 18 Through 64 Years of Age","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588686","publication_url":"https://clinicaltrials.gov/study/NCT06588686","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.","has_exemption":false,"start_date":"2024-12-09","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Vicore Pharma AB","sponsor_slug":"vicore-pharma-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06718101","publication_url":"https://clinicaltrials.gov/study/NCT06718101","title":"A Phase 2 Multicenter Platform Trial of Targeted Immunomodulator Therapies for Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-12-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06648642","publication_url":"https://clinicaltrials.gov/study/NCT06648642","title":"An Open-label Clinical Trial of IR-TMS for AUD and Development of a Neurobiological Biomarker for Craving and Relapse Validated Using a Direct Biochemical Biomarker (Phosphatidylethanol) of Alcohol Use","has_exemption":false,"start_date":"2025-02-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843239","publication_url":"https://clinicaltrials.gov/study/NCT06843239","title":"A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Zura Bio Inc","sponsor_slug":"zura-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837845","publication_url":"https://clinicaltrials.gov/study/NCT05837845","title":"A Randomized Trial to Compare MDMA-assisted Cognitive Processing Therapy (aCPT) Versus a VA Standard-of-care CPT for the Treatment of Severe Posttraumatic Stress Disorder Among Veterans","has_exemption":false,"start_date":"2025-02-10","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Patricia Suppes","sponsor_slug":"patricia-suppes","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455359","publication_url":"https://clinicaltrials.gov/study/NCT05455359","title":"The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms","has_exemption":false,"start_date":"2025-02-13","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798844","publication_url":"https://clinicaltrials.gov/study/NCT06798844","title":"Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease","has_exemption":false,"start_date":"2025-02-28","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Universitaire Ziekenhuizen KU Leuven","sponsor_slug":"universitaire-ziekenhuizen-ku-leuven","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05492266","publication_url":"https://clinicaltrials.gov/study/NCT05492266","title":"Expiratory Muscle Strength Training as a Non-surgical Option for Velopharyngeal Dysfunction: A Randomized-controlled Trial","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Noel Jabbour","sponsor_slug":"noel-jabbour","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06874621","publication_url":"https://clinicaltrials.gov/study/NCT06874621","title":"VY7523-102: A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Ascending Intravenous Doses of VY7523 in Participants With Early Alzheimer's Disease","has_exemption":false,"start_date":"2025-03-03","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Voyager Therapeutics","sponsor_slug":"voyager-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792695","publication_url":"https://clinicaltrials.gov/study/NCT06792695","title":"A Phase II, Open-label, Multicenter, Master Protocol to Evaluate the Safety and Efficacy of Novel Study Interventions and Combinations in Participants With Colorectal Cancer (CANTOR)","has_exemption":false,"start_date":"2025-03-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06843577","publication_url":"https://clinicaltrials.gov/study/NCT06843577","title":"A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects","has_exemption":false,"start_date":"2025-03-27","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Zona Health, Inc","sponsor_slug":"zona-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568601","publication_url":"https://clinicaltrials.gov/study/NCT06568601","title":"Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858111","publication_url":"https://clinicaltrials.gov/study/NCT06858111","title":"Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM)","has_exemption":false,"start_date":"2025-04-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Gameto, Inc.","sponsor_slug":"gameto-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919926","publication_url":"https://clinicaltrials.gov/study/NCT06919926","title":"A Randomized, Within-subject, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of AGB101 (Low-dose Levetiracetam, 220 mg, Extended Release Tablet) for the Treatment of Hippocampal Overactivity in the Elderly","has_exemption":false,"start_date":"2025-04-17","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06988670","publication_url":"https://clinicaltrials.gov/study/NCT06988670","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Extend Biosciences Inc.","sponsor_slug":"extend-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935357","publication_url":"https://clinicaltrials.gov/study/NCT06935357","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)","has_exemption":false,"start_date":"2025-05-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07010029","publication_url":"https://clinicaltrials.gov/study/NCT07010029","title":"Coronary Sinus Reducer in Patients With Angina With no Obstructive Coronary Disease: a Prospective Single-arm Study","has_exemption":false,"start_date":"2025-05-12","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of Warsaw","sponsor_slug":"medical-university-of-warsaw","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197268","publication_url":"https://clinicaltrials.gov/study/NCT07197268","title":"An Open-Label Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for Bainbridge-Ropers Syndrome Due to ASXL3 Gene Variant","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"n-Lorem Foundation","sponsor_slug":"n-lorem-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06996379","publication_url":"https://clinicaltrials.gov/study/NCT06996379","title":"Use of the J-Tip Needle-Free Injection System With 1% Lidocaine to Reduce Paracentesis-Related Discomfort","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921837","publication_url":"https://clinicaltrials.gov/study/NCT06921837","title":"A Phase 1/2, First-in-Human, Dose Escalation and Expansion Study of BDC-4182 as a Single Agent in Patients With Advanced Gastric and Gastroesophageal Cancer","has_exemption":false,"start_date":"2025-05-26","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Bolt Biotherapeutics, Inc.","sponsor_slug":"bolt-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06729996","publication_url":"https://clinicaltrials.gov/study/NCT06729996","title":"Randomized, Parallel Group, Dose Escalation Trial of Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus: The PEP-DM Trial","has_exemption":false,"start_date":"2025-05-29","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204912","publication_url":"https://clinicaltrials.gov/study/NCT07204912","title":"Evaluation of a Neural-Controlled Powered Prosthesis Across Diverse Real-World Tasks","has_exemption":false,"start_date":"2025-05-31","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Institute of Technology","sponsor_slug":"massachusetts-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07018323","publication_url":"https://clinicaltrials.gov/study/NCT07018323","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease","has_exemption":false,"start_date":"2025-06-19","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092059","publication_url":"https://clinicaltrials.gov/study/NCT07092059","title":"Decentralized Clinical Trial of Contingency Management Digital Therapeutic to Treat Stimulant Use Disorder","has_exemption":false,"start_date":"2025-06-24","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"DynamiCare Health","sponsor_slug":"dynamicare-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076407","publication_url":"https://clinicaltrials.gov/study/NCT07076407","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder","has_exemption":false,"start_date":"2025-07-08","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07103668","publication_url":"https://clinicaltrials.gov/study/NCT07103668","title":"An Open-label, Randomized, Comparative Phase III Study Including Patients With CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer.","has_exemption":false,"start_date":"2025-08-06","completion_date":"2027-05-31","has_results":false,"results_due":false,"sponsor_name":"Suzhou Immunofoco Biotechnology Co., Ltd","sponsor_slug":"suzhou-immunofoco-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null}]}